Chronic Periodontitis Clinical Trial
Official title:
Two-year Randomized Clinical Trial of Enamel Matrix Derivative Treated Infrabony Defects: Radiographic Analysis
This is a split-mouth, double-blind randomized controlled trial. Computerized linear radiographic measurements were used to detect infrabony defects treated with open flap debridement (OFD) or OFD associated with enamel matrix derivative (EMD), after 24 months. Ten patients presenting 2 or more defects were selected (43 defects). An individualized film holder was used to take standardized radiographs at baseline and after 24 months. Images were digitized and used to measure the distances from the cemento-enamel junction (CEJ) to the alveolar crest (AC), CEJ to the bottom of the defect (BD) and infrabony defect angle.
This was a split-mouth randomized controlled trial. Patients were recruited among the ones
seeking for periodontal treatment at the Post-graduate Clinic of Periodontics using the
following inclusion criteria: (1) diagnosis of chronic periodontitis15; (2) presence of at
least one pair of interproximal infrabony defects (2-3 walls) adjacent to vital anterior or
premolar teeth; (3) absence of 2 and 3 mobility degrees16; (4) probing pocket depth (PPD)≥
5mm; (5) full-mouth plaque score ≤ 20%17; and (6) keratinized tissue width of at least 2mm.
The exclusion criteria were: (1) presence of any systemic disease that could interfere with
periodontal treatment; (2) infrabony defects with trans-surgical depth ≤4mm; (3) antibiotic
treatment administered during the last 6 months.
The patients participating in the study were volunteers who received and gave informed
consent and were included in the study from June to October 2002.
Following initial examination, all patients underwent oral hygiene instruction and
full-mouth supra- and sub-gingival scaling and root planning under local anesthesia.
Patients were re-evaluated after completion of the initial therapy to determine their
response to therapy and to confirm the need for periodontal surgery. Before surgery, for
each pair of defects, one defect was randomly assigned to test (EMD) and one to control
(OFD) treatment by toss of a coin. Both defects were treated at the same surgical time. When
a patient presented with more than one pair of defects, only one pair was treated per day.
Following local anesthesia, all sites were treated with reflection of a full thickness
mucoperiosteal flap after intra-sulcular incisions. The exposed roots and osseous defects
were debrided with hand instruments, and the surgical wound was rinsed with saline.
After that, the flaps of the OFD sites were repositioned and sutured using 5-0 nylon
sutures. The EMD sites were dried with non-woven gauze, roots were conditioned with 24%
ethylenediaminotetracetic acid (EDTA) gel (pH 6.7) for 2 minutes. The defect was thoroughly
rinsed with saline, and EMD gel was applied to the root surfaces according to the
manufacturer's instructions. The flaps were then replaced for primary closure and sutured
with 5-0 nylon sutures. The sutures were removed after 7 days. All surgeries were performed
by the same investigator. All patients were prescribed 0.12% chlorhexidine digluconate and
instructed to rinse gently twice a day for 4 weeks. Analgesics were prescribed to be taken
as needed, and all patients were seen once a week, for 8 weeks, for professional tooth
cleaning. Subsequently, the patients were maintained in a supportive periodontal program
(ie, professional tooth cleaning and reinforcement of self-administered oral hygiene
measures) at 2-month intervals up to 6-month time and then every 3 months until final
examination at 24 months.
Standardized periapical radiographs were taken at baseline evaluation, immediately before
surgery and at 24 months follow-up. Individually customized bite blocks employing a
reference occlusal stent and film holders were used to obtain reproducible exposed films at
each radiographic control. All radiographs were evaluated by a single calibrated examiner,
blind to time and treatment.
Analyses of the radiographic outcomes were performed using computerized linear measurements
with image analysis software. The radiographs were previously scanned in digital format by a
scanner at a resolution of 500dpi/8bits.
The radiographic analysis was based in anatomical landmarks (CEJ, BD and AC) that were
identified on the scanned radiographs. All linear measurements were recorded by a blinded,
calibrated examiner. The following outcomes were measured at radiographs taken at baseline
and after 24 months:
1. Distance from the CEJ to the bottom of the defect (BD). The most coronal area where the
periodontal ligament maintained an even width was identified to measure the most apical
extension of the infrabony defect;
2. Distance from the CEJ to the bone crest (BC);
3. Infrabony defect angle was defined by two lines that represented the root surface of
the involved tooth (CEJ-BD) and the bone defect surface (BD-BC).
The distance from the CEJ to the bottom of the defect (BD) was considered the primary
outcome. CEJ-BC and defect angle were secondary outcomes
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06400069 -
Role of NLRP6 in Chronic Periodontitis
|
||
Completed |
NCT05231096 -
Comparison of the Effect of Gingival Massage of Aloe-vera Gel and Sidr Honey on Chronic Periodontitis
|
N/A | |
Completed |
NCT03203746 -
Gingival Crevicular Fluid Levels of Protein Carbonyl Following the Use of Lycopene in Chronic Periodontitis
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03354338 -
Amoxicillin to Prevent Bacteria and Inflammatory Biomarkers After Intensive Periodontal Therapy
|
Phase 2 | |
Completed |
NCT02516111 -
Comparison of Autologous PRF, 1% Alendronate and 1.2% Atorvastatin Gel in Chronic Periodontitis Treatment
|
Phase 2/Phase 3 | |
Completed |
NCT02174146 -
Leptin and Visfatin in Diabetic Patients With Periodontitis Before and After Periodontal Therapy
|
N/A | |
Terminated |
NCT02568163 -
Influence of Stress on Non Surgical Periodontal Treatment
|
N/A | |
Completed |
NCT02430519 -
Benefits of Platelet Rich Fibrin In Mandibular Molar Furcation Defects
|
N/A | |
Completed |
NCT01438333 -
Efficacy of INERSAN in Patients With Chronic Periodontitis as Adjunctive to Full Mouth Disinfection
|
N/A | |
Completed |
NCT01233765 -
Analysis of Neutrophil Response in Chronic Periodontitis
|
N/A | |
Completed |
NCT02218515 -
Treatment of Intrabony Periodontal Defects With Enamel Matrix Derivatives and Autogenous Bone Graft
|
Phase 4 | |
Completed |
NCT02197260 -
Antimicrobial Therapy as Adjunct to Periodontal Treatment: Effect of Timing
|
Phase 4 | |
Not yet recruiting |
NCT03270280 -
Comparison of Salivary Interleukin-1β and Matrix Metalloproteinase-8 Levels in Individuals With Chronic Periodontitis
|
Phase 2 | |
Not yet recruiting |
NCT04026828 -
Evaluation of Possible Genes in Periodontal Diseases by Genetic Methods
|
||
Completed |
NCT04643288 -
Nanocrystalline Hydroxyapatite Bone Substitute for Treating Periodontal Intrabony Defects
|
N/A | |
Completed |
NCT04697199 -
The Adjunctive Effect of Probiotics to Non Surgical Treatment of Chronic Periodontitis
|
Phase 1 | |
Completed |
NCT03039244 -
Evaluation of Antimicrobial Photodynamic Therapy as an Adjunct to Periodontal Treatment in Smokers
|
N/A | |
Completed |
NCT02898675 -
Advantages of Autologous Platelet-Rich Fibrin Membrane on Growth Factor Levels and Periodontal Healing
|
N/A | |
Completed |
NCT02518152 -
Platelet Rich Fibrin+1% Alendronate in Treatment of Chronic Periodontitis
|
Phase 2/Phase 3 | |
Completed |
NCT02851823 -
Combined Use of Er:YAG and Nd:YAG Laser
|
N/A |